Zucco, Avery. The generation and characterization of a human induced pluripotent stem cell model for the tuberous sclerosis complex. Retrieved from https://doi.org/doi:10.7282/t3-9ahy-yx47
DescriptionTuberous sclerosis complex (TSC) is an autosomal dominant disorder caused by the mutation of either the TSC1 or TSC2 genes and characterized by the presence of benign cortical lesions known as cortical tubers. A large proportion of patients with TSC exhibit neurological symptoms including epilepsy and intellectual disability, and a further 50% meet the diagnostic criteria for Autism. However, the appearance of this broad spectrum of neurologic manifestations does not always correlate with the neuroanatomical defects common to TSC, suggesting the possibility of underlying functional defects affecting neural development in TSC patients. Here we have utilized neural progenitor cells (NPCs) capable of fully differentiating into neurons, which carry a heterozygous TSC2 mutation generated from patient-derived induced pluripotent stem cells (iPSCs) to investigate TSC cellular and molecular phenotypes. In these cell lines we observe that TSC2 +/ NPCs exhibit changes in cell signaling along the Akt/mTORC1 signaling axis. This pathway is classically affected in TSC, with elevated pS6 and decreased phospho-Akt levels known as neuropathological hallmarks in knockout mouse models and studies of abnormal human tissue. Consistent with these previous findings we observed a decrease in the activity of AKT as measured by levels of phospho-AKT Thr308 and Ser473. Evidence of increased mTORC1 signaling was seen in one patient, but not another, suggesting TSC2 heterozygosity may produce modest signaling changes near a functional threshold for generating a molecular phenotype in NPCs. TSC2 heterozygous NPCs also exhibited a reduced capacity to produce neurons in vitro, suggesting that neural development may be impacted in TSC. Moreover, this phenotype was reproduced upon AKT inhibition of control NPC lines, but was unaffected under treatment with rapamycin, suggesting that AKT signaling may play a more prominent role in mediating the neurodevelopmental defects of TSC than previously thought.